Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Diagnosis of Factor Xiii Deficiency Publisher Pubmed



Dorgalaleh A1 ; Tabibian S2 ; Hosseini MS2 ; Farshi Y2 ; Roshanzamir F2 ; Naderi M3 ; Kazemi A1 ; Zaker F4 ; Aghideh AN2 ; Shamsizadeh M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Hematology and Blood Transfusion, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Hematology and Blood Transfusion, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Pediatrics Hematology & Oncology, Ali Ebn-e Abitaleb Hospital Research Center for Children and Adolescents Health [RCCAH], Zahedan University of Medical Sciences, Zahedan, Iran
  4. 4. Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran
  5. 5. School of Nursing and Midwifery, Shahroud University of Medical Sciences, Shahroud, Iran

Source: Hematology Published:2016


Abstract

Background: Factor XIII (FXIII) deficiency is an extremely rare bleeding disorder with estimated incidence of one per two million. All routine coagulation tests are normal in FXIII deficiency (FXIIID), which complicates the diagnosis of this disorder. Precise diagnosis of FXIIID requires more specific tests, including qualitative tests as well as quantitative tests such as FXIII activity, antigen assays, and finally molecular studies to confirm FXIIID. Objective: This study was conducted to present different quantitative and qualitative methods as well as molecular approaches for screening and diagnosis of FXIIID with advantages and disadvantages of each method. Methods: All relevant English-language publications were searched in Medline (until 2015). Results and discussion: Clot solubility assay is the most widely used method for detection of FXIIID but it is not standardized. The sensitivity of this method is dependent upon different factors mainly clotting factors and the solubilizing agents; therefore, FXIII activity assay is recommended for screening of FXIIID. Among FXIII activity assays, photometric assay is more common but FXIII activity is overestimated in this assay due to lack of sample blank in commercial assay, which can have fatal consequences in severe FXIIID, for which fluorometric assay is an appropriate alternative preventing the overestimation observed in photometric assay. There are different methods for measurement of FXIII-A2, FXIII-B2, and FXIII-A2B2as well as detection and quantification of FXIII inhibitor, which are mentioned in detail in this review. There are no mutational hotspots in FXIII-A and FXIII-B genes with a few recurrent mutations in some populations; therefore, full sequencing of FXIII genes has remained a main molecular approach for confirmation of FXIIID. Conclusion: Familiarity with different methods for diagnosis of FXIIID and their advantages and disadvantages can help in appropriate and timely diagnosis of this disorder to prevent misdiagnosis of FXIIID and its fatal consequences. © 2015, © W. S. Maney & Son Ltd 2015.
Related Docs
View other Related Docs
1. Laboratory Diagnosis of Factor Xiii Deficiency, Routine Coagulation Tests With Quantitative and Qualitative Methods, Clinical Laboratory (2016)
2. Factor Xiii Deficiency in Iran: A Comprehensive Review of the Literature, Seminars in Thrombosis and Hemostasis (2015)
3. Guidelines for Laboratory Diagnosis of Factor Xiii Deficiency, Blood Coagulation and Fibrinolysis (2016)
4. First Cases of Severe Congenital Factor Xiii Deficiency in Southwestern Afghanistan in the Vicinity of Southeast of Iran, Blood Coagulation and Fibrinolysis (2015)
5. Risk and Management of Intracerebral Hemorrhage in Patients With Bleeding Disorders, Seminars in Thrombosis and Hemostasis (2022)
6. Coagulation Factor Xiii-A A614t Gene Variation Is Suggestive of Founder Effect in Iranian Patients With Sever Congenital Factor Xiii Deficiency, Journal of Cellular and Molecular Anesthesia (2016)
7. Effect of Social Factors on the Highest Global Incidence of Congenital Factor Xiii Deficiency in Southeast of Iran, Archives of Iranian Medicine (2015)
8. Diagnosis, Clinical Manifestations and Management of Rare Bleeding Disorders in Iran, Hematology (2017)
Experts (# of related papers)
View all Related Experts
Shaban Alizadeh (9)
Zahra Kashanikhatib (2)
Other Related Docs
9. Association Between Expression of Mmp-2 and Mmp-9 Genes and Pathogenesis of Intracranial Hemorrhage in Severe Coagulation Factor Xiii Deficiency, Hematology (United Kingdom) (2015)
10. Relationship Between the Matrix Metalloproteinases and the Occurrence of Central Nervous System Bleeding in Factor Xiii Deficiency, Journal of Isfahan Medical School (2015)
11. Central Nervous System Bleeding in Pediatric Patients With Factor Xiii Deficiency: A Study on 23 New Cases, Hematology (2015)
12. Establishment of a Prenatal Diagnosis Schedule As Part of a Prophylaxis Program of Factor Xiii Deficiency in the Southeast of Iran, Blood Coagulation and Fibrinolysis (2016)
13. Challenges in Implementation of Isth Diagnostic Algorithm for Diagnosis and Classification of Factor Xiii Deficiency in Iran, Journal of Thrombosis and Haemostasis (2015)